Generate a tailored SOP for Dr. Benjamin Derman. Improve your application with a focused, well-structured draft.
Ben Derman, MD, specializes in hematology oncology. Dr. Derman is an expert in multiple myeloma and plasma cell disorders, including monoclonal gammopathy, amyloidosis, and plasmacytoma, and he utilizes innovative techniques such as CAR T-cell therapy and stem cell transplantation to deliver long-term success to his patients. In addition to his clinical practice, Dr. Derman is committed to research. He currently focuses on identifying strategies that may lead to a potential cure for multiple myeloma, using sensitive tests to measure small amounts of residual cancer cells in the body known as ‘minimal residual disease’ (MRD) to guide treatment decisions. He is actively investigating new methods and therapies designed to improve patient outcomes and quality of life. Additionally, Dr. Derman is interested in evaluating the reasons behind racial disparities in multiple myeloma outcomes to better understand care for patients. His work has been published in peer-reviewed journals including the Journal for Immunotherapy of Cancer, Blood, Blood Cancer Journal, and Leukemia & Lymphoma.
Department of Philosophy